ObsEva (NASDAQ:OBSV) Coverage Initiated at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a report issued on Friday. The firm set a “hold” rating on the stock.

ObsEva Stock Performance

The firm has a market capitalization of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68. ObsEva has a 52 week low of $0.08 and a 52 week high of $2.14. The stock has a 50-day moving average of $0.01.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.